Haringsma J - Search Results

1

5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial.

Hage M, Siersema PD, van Dekken H, Steyerberg EW, Haringsma J, van de Vrie W, Grool TE, van Veen RL, Sterenborg HJ, Kuipers EJ. Hage M, et al. Among authors: haringsma j. Gut. 2004 Jun;53(6):785-90. doi: 10.1136/gut.2003.028860. Gut. 2004. PMID: 15138203 Free PMC article. Clinical Trial.

2

Molecular evaluation of ablative therapy of Barrett's oesophagus.

Hage M, Siersema PD, Vissers KJ, Steyerberg EW, Haringsma J, Kuipers EJ, van Dekken H. Hage M, et al. Among authors: haringsma j. J Pathol. 2005 Jan;205(1):57-64. doi: 10.1002/path.1685. J Pathol. 2005. PMID: 15586364 Clinical Trial.

3

Genomic analysis of Barrett's esophagus after ablative therapy: persistence of genetic alterations at tumor suppressor loci.

Hage M, Siersema PD, Vissers KJ, Dinjens WN, Steyerberg EW, Haringsma J, Kuipers EJ, van Dekken H. Hage M, et al. Among authors: haringsma j. Int J Cancer. 2006 Jan 1;118(1):155-60. doi: 10.1002/ijc.21302. Int J Cancer. 2006. PMID: 16032707

4

In situ light dosimetry during photodynamic therapy of Barrett's esophagus with 5-aminolevulinic acid.

van Veen RL, Aalders MC, Pasma KL, Siersema PD, Haringsma J, van de Vrie W, Gabeler EE, Robinson DJ, Sterenborg HJ. van Veen RL, et al. Among authors: haringsma j. Lasers Surg Med. 2002;31(5):299-304. doi: 10.1002/lsm.10129. Lasers Surg Med. 2002. PMID: 12430146 Clinical Trial.

5

The homeodomain protein CDX2 is an early marker of Barrett's oesophagus.

Moons LM, Bax DA, Kuipers EJ, Van Dekken H, Haringsma J, Van Vliet AH, Siersema PD, Kusters JG. Moons LM, et al. Among authors: haringsma j. J Clin Pathol. 2004 Oct;57(10):1063-8. doi: 10.1136/jcp.2003.015727. J Clin Pathol. 2004. PMID: 15452161 Free PMC article.

6

A new esophageal stent design (Niti-S stent) for the prevention of migration: a prospective study in 42 patients.

Verschuur EM, Homs MY, Steyerberg EW, Haringsma J, Wahab PJ, Kuipers EJ, Siersema PD. Verschuur EM, et al. Among authors: haringsma j. Gastrointest Endosc. 2006 Jan;63(1):134-40. doi: 10.1016/j.gie.2005.07.051. Gastrointest Endosc. 2006. PMID: 16377330

7

Long-term risk of oesophagitis, Barrett's oesophagus and oesophageal cancer in achalasia patients.

Leeuwenburgh I, Haringsma J, Van Dekken H, Scholten P, Siersema PD, Kuipers EJ. Leeuwenburgh I, et al. Among authors: haringsma j. Scand J Gastroenterol Suppl. 2006;(243):7-10. doi: 10.1080/00365520600664201. Scand J Gastroenterol Suppl. 2006. PMID: 16782616 Review.

8

High-grade dysplasia in Barrett's esophagus is associated with increased expression of calgranulin A and B.

Bax DA, Siersema PD, Haringsma J, Kuipers EJ, Vos AJ, Van Dekken H, Van Vliet AH, Kusters JG. Bax DA, et al. Among authors: haringsma j. Scand J Gastroenterol. 2007 Aug;42(8):902-10. doi: 10.1080/00365520601138189. Scand J Gastroenterol. 2007. PMID: 17613918

9

Noninvasive measurement of oxygen saturation of the microvascular blood in Barrett's dysplasia by use of optical spectroscopy.

Amelink A, Haringsma J, Sterenborg HJ. Amelink A, et al. Among authors: haringsma j. Gastrointest Endosc. 2009 Jul;70(1):1-6. doi: 10.1016/j.gie.2008.08.039. Epub 2009 Feb 27. Gastrointest Endosc. 2009. PMID: 19249768

10

Narrow band imaging for the detection of gastric intestinal metaplasia and dysplasia during surveillance endoscopy.

Capelle LG, Haringsma J, de Vries AC, Steyerberg EW, Biermann K, van Dekken H, Kuipers EJ. Capelle LG, et al. Among authors: haringsma j. Dig Dis Sci. 2010 Dec;55(12):3442-8. doi: 10.1007/s10620-010-1189-2. Dig Dis Sci. 2010. PMID: 20393882 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters